Tickers

1. Composite Trajectory Verdict

The income statement matters most for assessing INFQ's financial performance because the company is an early-stage quantum technology business where revenue growth, margin trajectory, and operating loss trends indicate whether the commercial platform is scaling efficiently; the balance sheet transformation is a one-time financing event, and cash flows are currently dominated by that event rather than recurring operations.

Composite Trajectory: Mixed

Revenue is growing rapidly (74% YTD YoY to $23.4M; 157% Q2 YoY to $13.5M), but net losses are widening faster (263% YTD YoY to $54.4M; 169% Q2 YoY to $24.7M), and gross margin declined from 31% to 20% YTD YoY (10-Q 2026-06-30, Condensed Statements of Operations). Operating cash burn improved YTD YoY (-$6.0M vs -$9.7M), though this was offset by $474M investing outflows and $529M financing inflows from the Business Combination (10-Q 2026-06-30, Condensed Statements of Cash Flows). The balance sheet strengthened dramatically post-combination, moving from a SPAC structure with a $424M redemption liability and -$77.6M shareholders' deficit (10-K 2025-12-31, Consolidated Balance Sheets) to $582M in cash and available-for-sale securities, zero debt, and $574M positive equity (10-Q 2026-06-30, Condensed Consolidated Balance Sheets).

2. Red Flags

• Net loss growth (263% YTD YoY) significantly outpaces revenue growth (74% YTD YoY), indicating operating leverage is negative (10-Q 2026-06-30, Condensed Statements of Operations).
• Gross margin compressed from 31% to 20% YTD YoY as cost of services surged 771% YoY to $13.1M (10-Q 2026-06-30, Condensed Statements of Operations).
• Stock-based compensation expense exploded to $20.4M YTD 2026 from $1.9M YTD 2025, driven by "front-loaded recognition of expense under the graded attribution method following the Closing" (10-Q 2026-06-30, MD&A).
• Accrued liabilities jumped to $46.3M at 6/30/2026 from $8.9M at 12/31/2025, primarily from $30.9M in unremitted tax withholdings on stock option exercises (10-Q 2026-06-30, Note 8).
• One customer represented 74% of YTD 2026 revenue and 40% of accounts receivable at 6/30/2026 (10-Q 2026-06-30, Note 1).
• The company "expects to continue to incur operating losses and higher operating expenses for the foreseeable future" and may need additional capital that "may not be available on acceptable terms, or at all" (10-Q 2026-06-30, MD&A).
• Immaterial error corrections were made across multiple prior periods for revenue recognition and loss provision methodology (10-Q 2026-06-30, Note 1).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Revenue increased 74% YTD YoY to $23.4M (10-Q 2026-06-30, Condensed Statements of Operations), driven by service revenue growth of 361% to $16.7M, while product revenue fell 31% to $6.8M. Government revenue concentration rose to 89% of total from 84% (10-Q 2026-06-30, Note 2). Gross profit grew only 11% YTD YoY to $4.7M as cost of revenue doubled (+103%), compressing gross margin from 31% to 20% (10-Q 2026-06-30, Condensed Statements of Operations). Research and development expense rose 116% YTD YoY to $22.6M and selling, general and administrative expense rose 283% to $46.1M, with stock-based compensation accounting for $18.5M of the combined increase (10-Q 2026-06-30, MD&A). Net loss widened 263% YTD YoY to $54.4M. Interest income provided a growing offset ($8.2M YTD 2026 vs $1.1M YTD 2025) from Business Combination proceeds invested in money market funds and securities (10-Q 2026-06-30, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Operating cash burn improved to -$6.0M YTD 2026 from -$9.7M YTD 2025, a $3.8M reduction, driven by an $18.7M increase in non-cash adjustments (primarily $18.5M higher stock-based compensation) and a $24.5M increase from working capital changes (largely a $38.0M rise in accrued liabilities from tax withholdings on option exercises) (10-Q 2026-06-30, MD&A). Investing cash outflows surged to -$474M YTD 2026 from -$1.1M YTD 2025, almost entirely from $530M in purchases of available-for-sale securities funded by Business Combination proceeds (10-Q 2026-06-30, Condensed Statements of Cash Flows). Financing inflows jumped to $529M YTD 2026 from $49M YTD 2025, primarily $528M net proceeds from the Business Combination (10-Q 2026-06-30, Condensed Statements of Cash Flows). Ending cash, cash equivalents, and restricted cash was $60.4M at 6/30/2026 versus $87.8M at 6/30/2025, but this excludes $522.5M in available-for-sale securities (10-Q 2026-06-30, Condensed Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

The Business Combination fundamentally transformed the balance sheet. At 12/31/2025 (pre-combination SPAC), total assets were $425M, dominated by $424M in trust account securities, with $424M in Class A shares subject to redemption and a -$77.6M shareholders' deficit (10-K 2025-12-31, Consolidated Balance Sheets). At 6/30/2026 (post-combination), total assets reached $641M, including $59.3M cash, $522.5M available-for-sale securities, $5.4M accounts receivable, and $5.8M inventory, with zero debt, no redeemable shares, and $574M positive stockholders' equity (10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Convertible redeemable preferred stock of $297M was fully converted. Current liabilities rose to $53.5M from $23.0M, driven by $46.3M accrued liabilities (including $30.9M tax withholdings payable) (10-Q 2026-06-30, Note 8). Operating lease liabilities totaled $14.5M (10-Q 2026-06-30, Condensed Consolidated Balance Sheets). The company states its liquid resources are sufficient for at least 12 months (10-Q 2026-06-30, MD&A).

6. Data Gaps

• Standalone Q1 2025 and Q3 2025 income statements for Legacy Infleqton to enable four-quarter trailing trends (only nine-month and six-month 2025 data provided in 10-Q 2025-09-30 and 10-Q 2025-06-30).
• Full-year 2025 results for Legacy Infleqton (the 10-K 2025-12-31 covers only the SPAC entity CCX, not the operating business).
• Quarterly cash flow statements for Q2 2026 and Q1 2026 individually (only YTD six-month data provided in 10-Q 2026-06-30).
• Segment reporting detail (company operates as single segment per 10-Q 2026-06-30, MD&A, but no segment breakdowns provided).
• Backlog or remaining performance obligation detail beyond the $22.5M disclosed for future periods (10-Q 2026-06-30, Note 2).
• Comparative balance sheet for Legacy Infleqton at 12/31/2025 (the 10-Q 2026-06-30 shows 12/31/2025 post-restatement but pre-combination).